StemCell Therapy

The study was also supported by Diabetes UK and JDRF, the type 1 diabetes charity.

Dr Elizabeth Robertson, Director of Research at Diabetes UK, the charity who supported the lead author of the study, said: "Diabetes UK is committed to increasing our understanding of the immune attack in type 1 diabetes and finding ways to stop it.

These new findings are an exciting step towards immunotherapies being used to prevent this serious condition from developing in those at high risk, or stop it from progressing in those already diagnosed."

Prof Colin Dayan from Cardiff University, the clinical Chief Investigator for the study, added: "It was encouraging to see that people who receive the treatment needed less insulin to control their blood glucose levels, suggesting that their pancreas was working better.

Karen Addington, UK Chief Executive of JDRF which funded the research, said: "Exciting immunotherapy research like this increases the likelihood that one day insulin-producing cells can be protected and preserved.

That would mean people at risk of Type 1 diabetes might one day need to take less insulin, and perhaps see a future where no one would ever face daily injections to stay alive."

The research was published in the journal Science Translational Medicine.

Originally posted here:
Immune systems of type 1 diabetics can be 'retrained' to stop destroying insulin, scientists show - Telegraph.co.uk

This entry was posted on August 12, 2017 at 6:41 pm and is filed under Immune System. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |